№ files_lp_4_process_2_47641
File format: docx
Character count: 9992
File size: 750 KB
This document outlines the duties and responsibilities of the Clinical Nurse Consultant for Melanoma at the Department of Health, focusing on clinical leadership and patient care in the oncology field, specifically for melanoma care in Tasmania.
Position Title:
Clinical Nurse Consultant - Melanoma
Position Number:
530812
Classification:
Registered Nurse Grade 6
Award/Agreement:
Nurses and Midwives (Tasmanian State Service) Award
Group/Section:
Northern Cancer Service
Position Type:
Fixed-Term, Part Time
Location:
North, North West
Reports to:
Nurse Unit Manager – W.P. Holman Clinic
Effective Date:
September 2024
Check Type:
Annulled
Check Frequency:
Pre-employment
Essential Requirements:
Registered with the Nursing and Midwifery Board of Australia as a Registered Nurse.
Desirable Requirements:
Relevant post graduate qualifications or willingness to complete the post graduate certificate in myeloma care nursing and / or cancer nursing.
Position Features:
There is the expectation that the staff member will be required to work for, or at other sites of the Northern Cancer Service.
Primary Purpose:
The Clinical Nurse Consultant (CNC) – Melanoma provides clinical leadership and direction to improve the quality and continuity of care and support provided to clients diagnosed with melanoma across the continuum of care in North/Northwest Tasmania.
Duties:
Plan, coordinate and provide advanced melanoma care management following medical referral across the continuum of care to clients with melanoma; from the point of diagnosis, treatment decision-making, rehabilitation, follow up and palliative care, where appropriate.
Year:
2024
Region / City:
North, North West Tasmania
Topic:
Clinical Nursing, Melanoma Care
Document Type:
Job Description
Institution:
Department of Health
Author:
Northern Cancer Service
Target Audience:
Health care professionals, nurses, clinical leadership in oncology
Period of Action:
September 2024 onwards
Approval Date:
September 2024
Date of Changes:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Study type:
Supplementary material
Cohort size:
93 patients
Disease:
Metastatic melanoma
Methods:
Multiplex immunofluorescence, image cytometry, Cox regression, LASSO analysis
Data type:
Tables and figures
Variables analyzed:
Clinicopathologic characteristics, cell density, proximity measurements, immune biomarkers
Statistical software:
R
Target population:
Patients with metastatic melanoma
Follow-up period:
5 years
Year:
2019
Region / city:
Australia
Theme:
Oncology, Chemotherapy
Document type:
Resubmission for PBS listing
Organ / institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
Bristol-Myers Squibb Australia Pty Ltd
Target audience:
Medical professionals, PBAC members
Validity period:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Year:
2018
Region / City:
N/A
Topic:
Melanoma surgery, coding, biopsy procedures
Document Type:
Guide
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Medical professionals involved in melanoma surgery
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2019
Region / city:
Australia
Topic:
Adjuvant melanoma treatment
Document type:
Public Summary Document
Organization / institution:
PBAC
Author:
PBAC
Target audience:
Healthcare professionals
Period of validity:
Not specified
Approval date:
July 2019
Date of changes:
July 2019
Year:
2025
Date:
October 30, 2025
Time:
5:00 PM
Field:
Oncology; Surgery
Topic:
Tumor-Infiltrating Lymphocyte (TIL) Therapy; Metastatic Melanoma
Document Type:
Continuing Education / Continuing Medical Education Activity Description
Organizing Institution:
Ascension
Accrediting Bodies:
Accreditation Council for Continuing Medical Education; Accreditation Council for Pharmacy Education; American Nurses Credentialing Center
Credit Designation:
1.50 IPCE credits; 1.50 ANCC contact hours
Target Audience:
Interdisciplinary healthcare team; Oncology and Surgery specialties
Faculty:
Jatandra Birney, PharmD, BCOP
Activity Coordinator:
Tari Hopper, BSN
Commercial Support:
None
Conflict of Interest Disclosure:
No relevant financial relationships disclosed
Year:
2023
Region / City:
Australia
Subject:
Healthcare, Medicare Benefits Schedule
Document Type:
Factsheet
Organization:
Department of Health and Aged Care
Author:
Department of Health and Aged Care
Target Audience:
Healthcare providers, referrers, private health insurance stakeholders
Effective Date:
1 November 2022
Amendment Date:
1 March 2023
Year:
2026
Institution:
Città della Salute e della Scienza of Turin, hospital
Document type:
Supplementary table
Subject:
Melanoma prognosis
Population:
Hypothetical patients
Variables:
Age, Breslow thickness, Ulceration, Regression, Histotype, Positive lymph nodes count, Tumour burden
Data type:
Cumulative incidence (CI)
Methodology:
Predicted probability calculations
Intended audience:
Medical researchers, clinicians
Year:
2022
Country:
Australia
Region:
National
Subject:
Melanoma excision services under Medicare Benefits Schedule
Document type:
Government policy update and amended item descriptors
Issuing body:
Department of Health and Aged Care
Consulted organisations:
Dermatology and Skin Services Advisory Group; Australian Medical Association; Australasian College of Dermatologists; Australian Society of Plastic Surgeons
Effective date:
1 November 2022
Last updated:
5 September 2022
MBS items affected:
31371–31376
New MBS items:
31377–31383
Clinical category:
Skin
Procedure type:
Type B Non-band specific
Target audience:
Dermatologists, plastic and reconstructive surgeons, general surgeons, general practitioners
Regulatory framework:
Medicare Benefits Schedule
Year:
1995-2012
Region / city:
Europe
Theme:
Melanoma incidence
Document type:
Research paper
Organization / institution:
Public Health Agency Northern Ireland
Author:
L. Sacchetto, R. Zanetti, H. Comber, C. Bouchardy, D.H. Brewster, P. Broganelli, M.D. Chirlaque, D. Coza, J. Galceran, A. Gavin, M. Hackl, A. Katalinic, S. Larønningen, M.W.J. Louwman, E. Morgan, T.E. Robsahm, M.J. Sanchez, L. Tryggvado´ttir, R. Tumino, E. Van Eycken, S. Vernon, V. Zadnik, S. Rosso
Target audience:
Healthcare professionals, researchers
Period of action:
1995-2012
Date of approval:
Not specified
Date of changes:
Not specified
DOI:
doi.org/10.1016/j.ejca.2017.10.031
Year:
2026
Region/Location:
Not specified
Subject:
Melanoma research
Document type:
Supplementary data tables
Institution:
Research laboratory / academic study
Author:
Not specified
Sample size:
NEVI (14), Primary Malignant Melanoma (23), Metastatic Melanoma (15)
Methods:
Immunohistochemistry for PD-L1, BRAF codon 600 genotyping, inflammatory scoring
Cell lines:
Human melanoma cultured cells
Treatment:
IFN-gamma induction
Data metrics:
%PD-L1 expression, inflammation score, ∆MFI for PD-L1 and MHC I
Context:
Archival melanoma tissue samples and cultured melanoma cell lines analyzed for PD-L1 expression, BRAF mutation status, and immune response markers in experimental study
Year:
2026
Research field:
Molecular biology / Oncology
Document type:
Supplementary material / Figures and dataset
Institution:
Unspecified research laboratory
Techniques:
RT-qPCR, RNAscope, Fluorescent microscopy, Confocal microscopy
Samples:
501Mel, MM047, MM099 cell lines; primary melanomas 1 and 2; cutaneous metastases
Genes analyzed:
MITF, SOX9, SOX10, BIRC3
Magnification:
10X, 20X, 40X, 100X
Data format:
Heatmaps, microscopy images, primer sequences
Purpose:
Analysis of gene expression patterns at single-cell and bulk RNA levels
Year:
2020
Region / city:
United States, Illinois
Theme:
Sunscreen efficacy, sunburn, melanoma, skin protection
Document type:
Academic article
Organization / institution:
Chiou Consulting Inc, National Institutes of Health
Author:
Win L. Chiou
Target audience:
Researchers, healthcare professionals, public health experts
Effective period:
2020
Approval date:
March 27, 2020
Modification date:
Not specified
Keywords:
sunscreen, sunburn, melanoma, skin aging/antiaging theory, UV Index, skin cancers
Year:
2023
Region / City:
N/A
Topic:
Medical Protocols
Document Type:
Protocol
Organization / Institution:
College of American Pathologists (CAP)
Authors:
Wonwoo Shon, DO; Priyadharsini Nagarajan, MD, PhD; David P. Frishberg, MD; Jeffery Gershenwald, MD; Jeffrey North, MD; Victor G. Prieto, MD, PhD; Richard A. Scolyer, BMedSci, MBBS, MD; Thomas J. Flotte, MD; Timothy H. McCalmont, MD; Bruce Robert Smoller, MD
Target Audience:
Pathologists, Medical Professionals
Effective Date:
September 2024
Approval Date:
December 2023
Date of Last Update:
December 2023
Year:
2025
Region / City:
Singapore
Topic:
Customs, Inter-Bank GIRO, Payment Procedures
Document Type:
Application Form
Agency / Organization:
Singapore Customs
Author:
Singapore Customs
Target Audience:
Entities with business transactions involving Singapore Customs
Effective Period:
Ongoing
Approval Date:
Not stated
Date of Amendments:
Not stated
Year:
1996–2017
Region:
King County, Washington, USA
Document Type:
Job Classification Summary
Agency:
King County
Position:
Identification Technician
FLSA Status:
Non-Exempt
Service Status:
Career Service
EEO Code:
3
Education and Experience Requirements:
Any combination demonstrating ability to perform duties
Licensing and Certification:
US citizenship, English literacy, background investigation, polygraph examination, Washington state driver license
Job Functions:
Fingerprint and palm print collection, facial and tattoo photography, DNA sampling, law enforcement coordination, latent print processing, court testimony
Year:
2015
Region / City:
UK
Subject:
Construction Safety, Design and Management
Document Type:
Guideline
Author:
Not specified
Target Audience:
Dutyholders in construction projects
Period of validity:
Ongoing, subject to regulatory updates
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Year
Topic:
Medical Licensing
Document Type:
Legal Regulation
Authority:
AS 08.64.100, AS 08.64.170, AS 08.64.336, AS 08.64.106, AS 08.64.326, AS 08.64.380, AS 08.64.107
Target Audience:
Healthcare Providers
Description:
Legal regulation on the delegation of routine medical duties by licensed healthcare providers.
Note:
Year
Document Type:
Clinical Research Delegation Log
Author:
Principal Investigator / Investigator of Record
Target Audience:
Research Staff
Form Reference:
SC-A-020 (Ver 13 – 07/22)
Date:
DD/MM/YYYY
Note:
Unique Entity Number
Singapore Customs’ Bank Account Number:
001-038761-8
Processing Time:
up to 4 weeks
IBG Termination:
Bank directly
Fee for Unsuccessful IBG Deduction:
Penalty may apply
Contact Email:
[email protected]